Status:
RECRUITING
Development and Analysis of a Stool Bank for Cancer Patients
Lead Sponsor:
Persephone Biosciences
Collaborating Sponsors:
Pharm-Olam International
Conditions:
Carcinoma, Non-Small-Cell Lung
Carcinoma, Colorectal
Eligibility:
All Genders
18+ years
Brief Summary
This study is aimed at understanding the impact of gut microbiota on efficacy of cancer therapies, in particular checkpoint inhibitors, and using the resulting information to design microbial immunoth...
Detailed Description
A growing body of evidence indicates that the composition of the gut microbiome can influence the efficacy of cancer drugs. For example, it has recently been demonstrated that the presence of certain ...
Eligibility Criteria
Inclusion
- Men or women who are ≥ 18 years old who are undergoing any type of cancer immunotherapy
- Subjects who are able to provide written informed consent
Exclusion
- Subjects with HIV, Hepatitis B, or Hepatitis C
- Subjects without the mental capacity to complete either a written or online questionnaire, alone or with assistance, or make sound decisions
- Women who are pregnant or who plan on becoming pregnant
- Women who are nursing
Key Trial Info
Start Date :
June 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04291755
Start Date
June 28 2019
End Date
December 31 2028
Last Update
April 5 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Compassionate Care Research Group, Inc.
Fountain Valley, California, United States, 92708
2
Bond and Steele Clinic, P.A.
Winter Haven, Florida, United States, 33881